{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:32:58Z","timestamp":1790019178327,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":1523,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ad.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T16:58:50Z","timestamp":1446656330000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Actualizaci\u00f3n en mastocitosis. Parte 1: fisiopatolog\u00eda, cl\u00ednica y diagn\u00f3stico"],"prefix":"10.1016","volume":"107","author":[{"given":"J.M.","family":"Aza\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Torrelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Matito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2015.09.007_bib0745","unstructured":"Prevalencia de las enfermedades raras: lista por orden de prevalencia decreciente o por n\u00famero de casos publicados. Informes peri\u00f3dicos Orphanet serie enfermedades raras 2014;2 [consultado 15 Mar 2015]. Disponible en http:\/\/ww.orpha.net\/orphacom\/cahiers\/docs\/ES\/"},{"key":"10.1016\/j.ad.2015.09.007_bib0750","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ad.2015.09.007_bib0535","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of indolent systemic mastocytosis in a Dutch region","volume":"131","author":"Van Doormaal","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0540","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semerg.2009.02.001","article-title":"Mastocitosis: actualizaci\u00f3n y aspectos de inter\u00e9s para el m\u00e9dico de Atenci\u00f3n Primaria","volume":"36","author":"Conejos-Miquel","year":"2010","journal-title":"Semergen"},{"key":"10.1016\/j.ad.2015.09.007_bib0545","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ad.2015.09.007_bib0550","first-page":"11","article-title":"Gu\u00edas cl\u00ednicas para el diagn\u00f3stico, tratamiento y seguimiento de las mastocitosis","volume":"31","author":"De la Hoz","year":"2008","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.ad.2015.09.007_bib0555","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000321954","article-title":"Clinical impact of pregnancy in mastocytosis: A study of the Spanish Network on Mastocytosis (REMA) in 45 Cases","volume":"156","author":"Matito","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0560","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.13567","article-title":"Paediatric mastocytosis: a systematic review of 1747 cases","volume":"172","author":"Meni","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.09.007_bib0755","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.09.007_bib0760","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/DAD.0b013e31826330bf","article-title":"Familial urticaria pigmentosa: Report of a family and review of the role of KIT mutations","volume":"35","author":"Fett","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2015.09.007_bib0765","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ad.2015.09.007_bib0440","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00508-012-0293-z","article-title":"European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives","volume":"124","author":"Valent","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ad.2015.09.007_bib0770","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: A consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.ad.2015.09.007_bib0775","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","article-title":"Diagnostic criteria and classification of mastocytosis in 2014","volume":"34","author":"Akin","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ad.2015.09.007_bib0465","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow haematopoietic cell lineages in systemic mast cell disorders. A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garc\u00eda-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ad.2015.09.007_bib0780","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1525-1470.1994.tb00560.x","article-title":"Urticaria pigmentosa: A review of 67 pediatric cases","volume":"11","author":"Aza\u00f1a","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ad.2015.09.007_bib0785","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/adc.86.5.315","article-title":"Paediatric mastocytosis","volume":"86","author":"Carter","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ad.2015.09.007_bib0790","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11588890-000000000-00000","article-title":"Diagnosis and treatment of cutaneous mastocytosis in children: Practical recommendations","volume":"12","author":"Castells","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2015.09.007_bib0795","series-title":"Laboratory Hematology Practice","first-page":"388","article-title":"Diagnosis of Adult Mastocytosis: role for bone marrow analysis","author":"Escribano","year":"2012"},{"key":"10.1016\/j.ad.2015.09.007_bib0800","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ad.2015.09.007_bib0805","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/stem.5530050203","article-title":"Differentiation and transdifferentiation of mast cells: A unique member of the hematopoietic cell family","volume":"5","author":"Kitamura","year":"1987","journal-title":"Int J Cell Cloning"},{"key":"10.1016\/j.ad.2015.09.007_bib0810","first-page":"2207","article-title":"Organization and nucleotide sequence of the human KIT (mast\/stem cell growth factor receptor) proto-oncogene","volume":"7","author":"Giebel","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.ad.2015.09.007_bib0815","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.iac.2014.01.002","article-title":"Functional deregulation of KIT: Link to mast cell proliferative diseases and other neoplasms","volume":"34","author":"Cruse","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ad.2015.09.007_bib0820","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.iac.2014.01.009","article-title":"Molecular defects in mastocytosis: KIT and beyond KIT","volume":"34","author":"Bibi","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ad.2015.09.007_bib0825","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","article-title":"Development, migration, and survival of mast cells","volume":"34","author":"Okayama","year":"2006","journal-title":"Immunol Res"},{"key":"10.1016\/j.ad.2015.09.007_bib0830","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/eji.201040559","article-title":"Mast cells in allergy and infection: Versatile effector and regulatory cells in innate and adaptive immunity","volume":"40","author":"Galli","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0835","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0161-5890(02)00077-9","article-title":"Activation of human mast cells through the high affinity IgG receptor","volume":"38","author":"Tkaczyk","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0840","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.4049\/jimmunol.157.4.1693","article-title":"C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway","volume":"157","author":"Nilsson","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0845","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/eji.1830270925","article-title":"Human mast cells express functional TrkA and are a source of nerve growth factor","volume":"27","author":"Nilsson","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0850","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: Critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0855","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11882-014-0450-8","article-title":"Anaphylaxis as a clinical manifestation of clonal mast cell disorders","volume":"14","author":"Matito","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.ad.2015.09.007_bib0860","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000235369","article-title":"Functional heterogeneity of human mast cells","volume":"94","author":"Pearce","year":"1991","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0865","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nature Genet"},{"key":"10.1016\/j.ad.2015.09.007_bib0870","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ad.2015.09.007_bib0875","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MOP.0b013e328355b248","article-title":"Childhood mastocytosis","volume":"24","author":"Torrelo","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ad.2015.09.007_bib0880","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1747.1998.00414.x","article-title":"Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: A possible explanation for divergent clinical behavior","volume":"111","author":"Buttner","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.09.007_bib0885","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using PNA-mediated PCR-clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ad.2015.09.007_bib0890","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1525-1578(10)60552-1","article-title":"c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation","volume":"7","author":"Yanagihori","year":"2005","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ad.2015.09.007_bib0895","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000096907","article-title":"C-kit Asp-816-Val mutation analysis in patients with mastocytosis","volume":"214","author":"Verzijl","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2015.09.007_bib0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish network on mastocytosis (REMA)","volume":"58B","author":"Escribano","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.ad.2015.09.007_bib0905","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-12-385493-3.00014-0","article-title":"Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders","volume":"103","author":"S\u00e1nchez-Mu\u00f1oz","year":"2011","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.ad.2015.09.007_bib0910","first-page":"566","article-title":"Lack of interleukin-2 (IL-2) dependent growth of TAC positive T-ALL\/NHL cells is due to the expression of only low affinity receptors for IL-2","volume":"3","author":"Debatin","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.ad.2015.09.007_bib0915","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ad.2015.09.007_bib0920","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.iac.2014.01.008","article-title":"Flow cytometry in mastocytosis: Utility as a diagnostic and prognostic tool","volume":"34","author":"S\u00e1nchez-Mu\u00f1oz","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ad.2015.09.007_bib0925","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/his.12221","article-title":"CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis","volume":"63","author":"Morgado","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.ad.2015.09.007_bib0600","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis. Current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ad.2015.09.007_bib0605","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000083954","article-title":"Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes","volume":"136","author":"Florian","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0610","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: A study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2015.09.007_bib0615","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: A study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonz\u00e1lez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ad.2015.09.007_bib0620","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1399-3038.2011.01181.x","article-title":"Improving anaphylaxis management in a pediatric emergency department","volume":"22","author":"Arroabarren","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0625","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/all.12272","article-title":"The epidemiology of anaphylaxis in Europe: A systematic review","volume":"68","author":"Panesar","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2015.09.007_bib0630","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0635","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaci.2012.10.052","article-title":"Systemic mastocytosis as a risk factor for severe hymenoptera sting-induced anaphylaxis","volume":"131","author":"Alvarez-Twose","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0640","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","article-title":"Bone involvement and osteoporosis in mastocytosis","volume":"34","author":"Rossini","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ad.2015.09.007_bib0645","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0650","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1398-9995.2011.02780.x","article-title":"High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis","volume":"67","author":"van der Veer","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2015.09.007_bib0655","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1111\/1523-1747.ep12468899","article-title":"Systemic mastocytosis: Retrospective review of a decade's clinical experience at the Brigham and Women's Hospital","volume":"96","author":"Horan","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.09.007_bib0660","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological and molecular characteristics of systemic mast cell disorders presenting with severe mediator-related symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0665","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaip.2014.03.007","article-title":"Mast cell activation disorders","volume":"2","author":"Akin","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ad.2015.09.007_bib0670","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archdermatol.2011.190","article-title":"Dermoscopic features of skin lesions in patients with mastocytosis","volume":"147","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2015.09.007_bib0675","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0091-6749(88)90015-2","article-title":"A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders","volume":"82","author":"Garriga","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0680","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000315946","article-title":"Mastocytosis","volume":"95","author":"Brockow","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.ad.2015.09.007_bib0685","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","article-title":"Clinical and histopathological aspects of cutaneous mastocytosis","volume":"25","author":"Wolff","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.ad.2015.09.007_bib0690","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/all.12436","article-title":"Proposed diagnostic algorithm for patients with suspected mastocytosis: A proposal of the European Competence Network on Mastocytosis","volume":"69","author":"Valent","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2015.09.007_bib0695","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: General histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.ad.2015.09.007_bib0700","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric. Analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.ad.2015.09.007_bib0705","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ad.2015.09.007_bib0710","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11882-006-0061-0","article-title":"Urticaria pigmentosa and mastocytosis: The role of immunophenotyping in diagnosis and determining response to treatment","volume":"6","author":"Akin","year":"2006","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.ad.2015.09.007_bib0715","doi-asserted-by":"crossref","first-page":"e76116","DOI":"10.1371\/journal.pone.0076116","article-title":"Serum tryptase monitoring in indolent systemic mastocytosis: Association with disease features and patient outcome","volume":"8","author":"Matito","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ad.2015.09.007_bib0720","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2004.02.032","article-title":"Expression of alpha-tryptase and beta-tryptase by human basophils","volume":"113","author":"Jogie-Brahim","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0725","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01533368","article-title":"Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis","volume":"14","author":"Schwartz","year":"1994","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0730","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: Correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ad.2015.09.007_bib0735","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","article-title":"Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis","volume":"67","author":"Alvarez-Twose","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2015.09.007_bib0740","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1398-9995.2012.02809.x","article-title":"Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions","volume":"67","author":"Van Doormaal","year":"2012","journal-title":"Allergy"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015004019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015004019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:04:24Z","timestamp":1757552664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731015004019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0001731015004019"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2015.09.007","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualizaci\u00f3n en mastocitosis. Parte 1: fisiopatolog\u00eda, cl\u00ednica y diagn\u00f3stico","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}